Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 58.69% is in line with its 5-year average of 64.19%, near the low end of its 5-year range (55.94%–76.22%).
0.88% below its 12-month average of 59.21%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 59.59%.
GROSS MARGIN
58.69%
GROSS MARGIN AVG TTM
59.21%
GROSS MARGIN AVG 3Y
59.60%
GROSS MARGIN AVG 5Y
64.19%
GROSS MARGIN AVG 10Y
61.85%
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-0.88%
CURRENT VS 3Y AVG
-1.53%
CURRENT VS 5Y AVG
-8.57%
CURRENT VS 10Y AVG
-5.11%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-0.52%
vs the sector median at left
TransMedics Group, Inc.
Market Cap
$2.99B
Gross Margin
58.69%
TTM Avg
59.21%
3Y Avg
59.60%
5Y Avg
64.19%
Market Cap
$1.91B
Gross Margin
49.52%
TTM Avg
50.81%
3Y Avg
52.12%
5Y Avg
52.25%
Market Cap
$1.14B
Gross Margin
73.53%
TTM Avg
70.13%
3Y Avg
70.04%
5Y Avg
68.74%
Market Cap
$5.10B
Gross Margin
49.52%
TTM Avg
48.04%
3Y Avg
46.91%
5Y Avg
45.73%
Market Cap
$5.59B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
-67.67%
5Y Avg
-188.00%
Market Cap
$376.61M
Gross Margin
77.34%
TTM Avg
76.74%
3Y Avg
77.57%
5Y Avg
77.57%
Market Cap
$45.05M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TransMedics Group, Inc. (TMDX) | $2.99B | 58.69% | 59.21% | 59.60% | 64.19% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.91B | 49.52% | 50.81% | 52.12% | 52.25% |
| Teladoc Health, Inc. (TDOC)vs › | $1.14B | 73.53% | 70.13% | 70.04% | 68.74% |
| Doximity, Inc. (DOCS)vs › | $4.88B | 88.07% | 89.65% | 88.97% | 88.20% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 49.52% | 48.04% | 46.91% | 45.73% |
| NRC Health (NRC)vs › | $463.35M | 56.33% | 58.27% | 60.30% | 61.48% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.59B | 0.00% | 0.00% | -67.67% | -188.00% |
| Shoulder Innovations, Inc. (SI)vs › | $376.61M | 77.34% | 76.74% | 77.57% | 77.57% |
| PDS Biotechnology Corporation (PDSB)vs › | $45.05M | 0.00% | 0.00% | 0.00% | 0.00% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.24B | 73.84% | 76.65% | 78.21% | 76.94% |
Gross Margin
58.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 59.59% |
| 2026-03-31 | 58.16% |
| 2025-12-31 | 58.11% |
| 2025-09-30 | 58.80% |
| 2025-06-30 | 61.38% |
| 2025-03-31 | 61.47% |
| 2024-12-31 | 59.21% |
| 2024-09-30 | 55.94% |
| 2024-06-30 | 60.51% |
| 2024-03-31 | 61.81% |
| 2023-12-31 | 59.04% |
| 2023-09-30 | 61.21% |
| 2023-06-30 | 70.03% |
| 2023-03-31 | 69.23% |
| 2022-12-31 | 65.99% |
| 2022-09-30 | 70.53% |
| 2022-06-30 | 69.93% |
| 2022-03-31 | 76.22% |
| 2021-12-31 | 72.26% |
| 2021-09-30 | 70.26% |
| 2021-06-30 | 68.40% |
| 2021-03-31 | 68.21% |
| 2020-12-31 | 63.30% |
| 2020-09-30 | 71.05% |
| 2020-06-30 | 56.30% |
| 2020-03-31 | 64.54% |
| 2019-12-31 | 61.76% |
| 2019-09-28 | 58.51% |
| 2019-06-29 | 58.82% |
| 2019-03-30 | 55.03% |
| 2018-12-31 | 42.30% |
| 2018-09-30 | 52.79% |
| 2018-06-30 | 40.45% |
| 2018-03-31 | 36.68% |
| 2017-12-30 | 25.12% |
| 2017-09-30 | 25.98% |
| 2017-07-01 | 36.34% |
| 2017-04-01 | 30.25% |
